Q32 Bio (QTTB) Invested Capital (2017 - 2026)

Q32 Bio has reported Invested Capital for 10 years, with the latest figure at $52.6 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 8009.88% year-over-year to $52.6 million; the trailing twelve-month figure through Mar 2026 stood at $52.6 million (up 8009.88% YoY), and the FY2025 full-year result was $48.2 million, up 450.03% from the prior year.
• Invested Capital for Q1 2026 stood at $52.6 million, up from $48.2 million in the prior quarter.
• The five-year high for Invested Capital was $266.3 million in Q1 2022, with the low at -$182.0 million in Q4 2023.
• Average Invested Capital over 5 years is $9.6 million, with a median of $8.8 million recorded in 2024.
• Year-over-year, Invested Capital sank 177.05% in 2022 and soared 8009.88% in 2026.
• Tracing QTTB's Invested Capital over 5 years: stood at -$130.7 million in 2022, then plunged by 39.27% to -$182.0 million in 2023, then surged by 104.82% to $8.8 million in 2024, then surged by 450.03% to $48.2 million in 2025, then gained by 8.92% to $52.6 million in 2026.
• The last three Invested Capital figures came in at $52.6 million (Q1 2026), $48.2 million (Q4 2025), and -$12.2 million (Q3 2025), per Business Quant data.

Peer Comparison